Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rexall Sundown

This article was originally published in The Tan Sheet

Executive Summary

Company agrees to purchase Worldwide Sport Nutritional Supplements for $71.5 mil. cash. Worldwide, a privately held sports nutritionals firm that markets the Pure Protein line of bars and drinks, posted net sales of approximately $42 mil. in fiscal 1999. The acquisition is expected to close in March and will be slightly accretive in FY 2000. The deal builds upon Boca Raton, Fla.-based Rexall's growing foothold in the sports nutritionals category. Rexall recently acquired the sports nutrition firm Met-Rx Nutrition for $108 mil. (1"The Tan Sheet" Dec. 20, 1999, p. 3). Worldwide President and CEO David McCabe will retain his position

You may also be interested in...



Rexall Retail Sales Soar 43% To $135 Mil. In Second Quarter

Osteo Bi-Flex, Metab-O-Lite and the recently acquired Met-Rx business led Rexall Sundown to a 27% sales jump in the fiscal second quarter ended Feb. 29, the firm announced March 23.

Rexall Retail Sales Soar 43% To $135 Mil. In Second Quarter

Osteo Bi-Flex, Metab-O-Lite and the recently acquired Met-Rx business led Rexall Sundown to a 27% sales jump in the fiscal second quarter ended Feb. 29, the firm announced March 23.

Rexall Retail Sales Soar 43% To $135 Mil. In Second Quarter

Osteo Bi-Flex, Metab-O-Lite and the recently acquired Met-Rx business led Rexall Sundown to a 27% sales jump in the fiscal second quarter ended Feb. 29, the firm announced March 23.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090910

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel